Author(s):
Zh. M. Polova, L. P. Babenko, T. Nehoda
Email(s):
tetiananegoda570@gmail.com
DOI:
10.52711/0974-360X.2025.00542 
Address:
Zh. M. Polova1, L. P. Babenko2, T. Nehoda1
1O.O. Bogomolets National Medical University, Kyiv, 13 T. Shevchenko boul., Kyiv, 01601, Ukraine.
2Zabolotny Institute of Microbiology and Virology, NAS of Ukraine, 154 Acad. Zabolotny Str., Kyiv, 03143, Ukraine.
*Corresponding Author
Published In:
Volume - 18,
Issue - 8,
Year - 2025
ABSTRACT:
Bacterial vaginosis and vulvovaginal candidiasis are the most common local pathologies of the female urogenital tract, which are accompanied by a decrease or complete disappearance of lactobacilli against the ba ckground of the growth of pathogenic microorganisms. Effective treatment and prevention of dysbiotic disorders can be achieved by the use of medications containing lactobacilli strains in the form of intravaginal dosage forms, such as pessaries. Microbial strains used as active pharmaceutical ingredients for the development of such drugs must possess certain physicochemical and microbiological properties. The objective of this study is to study the microbiological properties of Lactobacillus casei IMV B-7280 strain in the composition of pessaries with probiotic activity, including lactic acid production, antagonistic and adhesive properties, sensitivity to antibacterial and antifungal medicines. Methods. The adhesive properties of L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity were determined using the Brilis method on buccal epithelium culture. The antagonistic activity of L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity was determined by the method of perpendicular strokes. The lactic acid production ability of L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity was determined by the acid-base titration method. The sensitivity of L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity to antibiotics and antifungal medicines was determined by the diffusion method in agar on a nutrient medium. Results. The determination of lactic acid production ability resulted in an average value of oT = 183.8 ± 1.5 indicating a high ability of L. casei IMV B-7280 strain to produce lactic acid and to lower the pH in the vaginal environment. The investigation of adhesive properties indicates that L. casei IMV B-7280 strain is highly adhesive, which allows for a high degree of adhesion when intravaginal pessaries are administered. The results of the antagonistic activity study of L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity indicate moderate antagonistic activity against pathogenic and opportunistic microorganisms. The highest antagonism of the tested probiotic strain is observed to Pseudomonas aeruginosa ATCC 9027 test-culture, while the lowest is observed to Staphylococcus aureus ATCC 6538 test- strain. It was found that L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity is resistant to vancomycin, oxacillin, linezolid, nystatin, furazolidone, and imidazole derivatives. This strain is sensitive to penicillin (except oxacillin), macrolides, lincomycins, cefoperazone, pefloxacin, and imipenem. It is moderately sensitive to cephalosporins (cefazolin and ceftriaxone) and fluoroquinolones (ciprofloxacin and levofloxacin). Conclusions. Microbiological studies of the adhesive properties, antagonistic activity, lactic acid production ability, and sensitivity to antibacterial and antifungal medicines of L. casei IMV B-7280 strain in the composition of pessaries with probiotic activity demonstrate compliance with the requirements for microbial strains used to develop medications with probiotic activity. The developed medication can be used in the complex treatment of vaginal dysbiosis, which improves therapy and promotes faster and better achievement of the clinical effect.
Cite this article:
Zh. M. Polova, L. P. Babenko, T. Nehoda. Research of Biological properties of Pessaries with Probiotic Activity containing Lactobacillus casei. Research Journal Pharmacy and Technology. 2025;18(8):3767-2. doi: 10.52711/0974-360X.2025.00542
Cite(Electronic):
Zh. M. Polova, L. P. Babenko, T. Nehoda. Research of Biological properties of Pessaries with Probiotic Activity containing Lactobacillus casei. Research Journal Pharmacy and Technology. 2025;18(8):3767-2. doi: 10.52711/0974-360X.2025.00542 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-8-45
REFERENCES:
1. Wijgert JH, Verwijs MC, Agaba SK, Bronowski C, Mwambarangwe L, Uwineza M, Lievens E, Nivoliez A, Ravel J, Darby AC. Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing. Sci Rep. 2020; 10(1). https://doi.org/10.1038/s41598-020-60671-6
2. Gandhi K, Garza J, Gutierrez P, Arispe R, Gomez Garcia J, Ventolini G. Vaginal Lactobacillus species and recurrent vulvovaginal candidiasis. Gynecol Reprod Endocrinol Metab. 2021; (2): 12-4.
3. Lin TC, Hsu IL, Tsai WH, Chu YC, Kuan LC, Huang MS, Yeh WL, Chen YH, Hsu SJ, Chang WW. Improvement of Bacterial Vaginosis by Oral Lactobacillus Supplement: A Randomized, Double-Blinded Trial. Appl Sci. 2021; 11(3): 902. https://doi.org/10.3390/app11030902
4. Reznichenko H, Henyk N, Maliuk V, Khyzhnyak T, Tynna Y, Filipiuk I, Veresniuk N, Zubrytska L, Quintens J, Richir K, Gerasymov S. Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study. J Low Genit Tract Dis. 2020; 24(3): 284-9. https://doi.org/10.1097/lgt.0000000000000518
5. Saduakhasova S, Kushugulova A, Shakhabayeva G, Kozhakhmetov S, Khasenbekova Z, Tynybayeva I, Nurgozhin T, Zhumadilov Z. Lactobacillus for Vaginal Microflora Correction. Central Asian J Glob Health. 2014; 3. https://doi.org/10.5195/cajgh.2014.171
6. Paniágua AL, Correia AF, Pereira LC, de Alencar BM, Silva FB, Almeida RM, de Medeiros Nóbrega YK. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals. BMC Complement Med Ther. 2021; 21(1). https://doi.org/10.1186/s12906-021-03405-z
7. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Candido RC, Ferreira JC, De Martinis EC, Reid G. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosusGR-1 and Lactobacillus reuteriRC-14. Lett Appl Microbiol. 2009; 48(3): 269-74. https://doi.org/10.1111/j.1472-765x.2008.02477.x
8. Wang Z, He Y, Zheng Y. Probiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis. Int J Environ Res Public Health. 2019; 16(20): 3859. https://doi.org/10.3390/ijerph16203859
9. Han Y, Ren QL. Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis. Curr Opin Pharmacol. 2021; 61: 83-90. https://doi.org/10.1016/j.coph.2021.09.004
10. Safronova, L., Pylypiuk, Y., Skorochod, I., & Polova, Z. Probiotics and Their Potential for the Prevention and Treatment of Infections. Mikrobiolohichnyi Zhurnal. 2024; 86(6). https://doi.org/10.15407/
11. G.Sreeramya, C.N.Nalini, Ramalakshmi.N, Kondaviti Sahini, Amudha Lakshmi.S. A new Era in Medicine – Neutraceuticals. Research J. Pharm. and Tech. 2018; 11(8): 3572-3576. doi.org/10.5958/0974-360X.2018.00657.1
12. Hütt P, Lapp E, Štšepetova J, Smidt I, Taelma H, Borovkova N, Oopkaup H, Ahelik A, Rööp T, Hoidmets D, Samuel K, Salumets A, Mändar R. Characterisation of probiotic properties in human vaginal lactobacilli strains. Microb Ecol Health Amp Dis. 2016; 27. https://doi.org/10.3402/mehd.v27.30484.
13. Coudeyras S, Jugie G, Vermerie M, Forestier C. Adhesion of Human ProbioticLactobacillus rhamnosusto Cervical and Vaginal Cells and Interaction with Vaginosis-Associated Pathogens. Infect Dis Obstet Gynecol. 2008; (1)5. https://doi.org/10.1155/2008/549640
14. Nimmy Abraham, Chitra Namachivayam, Sangeetha Sundaramoorthy. Lactobacillus- An friendly Bacteria. International Journal of Technology. 2021; 11(2): 70-7. doi.org/10.52711/2231-3915.2021.00010.
15. Shanthi V., Jemima Florence Borgia, Bhavani S., Sathya M. Inhibitory Effects of Lactobacillus Species Against Human Pathogens. Research J. Pharmacognosy and Phytochemistry 2011; 3(4): 174-177. doi.org/10.52711/0974-360X.2023.00394.
16. Siti Fatmawati, Rizky Dzariyani Laili, MM. Riyaniarti Estri Wuryandari, Erryana Martati, Tri Dewanti Widyaningsih, Muhaimin Rifa’i. Fermented Ethanolic Extract of Moringa oleifera leaves with Lactobacillus plantarum FNCC 0137 as Immunomodulators on Salmonella typhi-Infected Mice. Research J. Pharm. and Tech. 2020; 13(12): 5777-5782. doi.org/10.5958/0974-360X.2020.01007.0.
17. Mastromarino P, Vitali B, Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013; (36): 229-38.
18. Gil NF, Martinez R, Gomes BC, Nomizo A, De Martinis EC. Vaginal lactobacilli as potential probiotics against Candida spp. Braz J Microbiol. 2010; 41: 6-14. doi.org/10.1590/S1517-83822010000100002.
19. Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017; 168(9-10): 782-92. https://doi.org/10.1016/j.resmic.2017.04.001
20. Amr A. El-Waseif, Hussein S. Gaber, Emad A. Ewais. Hypocholesterolemic Operating Parameters of Novel Probiotics In vitro. Research Journal of Pharmacy and Technology. 2021; 14(10):5197-1. doi.org/10.52711/0974-360X.2021.00904.
21. Knysh OV, Kolpak SA, Pogorila MS, Babych YeM. Adhesive properties of bacteria under the influence of Bifidobacterium bifidum 1 and Lactobacillus reuteri DSM 17938i cell-free extracts Act. problems modern medicine. 2020; 20(2): 129-34. doi.org/10.31718/2077-1096.20.2.129.
22. Zeng Z, Zuo F, Marcotte H. Putative Adhesion Factors in Vaginal Lactobacillus gasseri DSM 14869: Functional Characterization. Appl Environ Microbiol. 2019; 85(19). https://doi.org/10.1128/aem.00800-19
23. Aditya A, Peng M, Young A, Biswas D. Antagonistic Mechanism of Metabolites Produced by Lactobacillus casei on Lysis of Enterohemorrhagic Escherichia coli. Front Microbiol. 2020; 11. https://doi.org/10.3389/fmicb.2020.574422
24. Babych EM, Kalinichenko SV, Korotkykh OO, Ryzhkova TA, Sklyar NI, Maslii IG, Balak AK, Shkodovska NYu, Bagacha MB. The study of the biological properties of probiotic Lactobacillus spp. strains under aerobic and microaerophilic cultivation conditions. Ann Mechnikov Inst. 2014; (1): 33-7.
25. Seema B Chauhan, Vinod Singh, Rajani Chauhan. Enteric coated Microbeads as a Potential Delivery System for improved probiotic effect of Lactobacillus rhamnosus GG. Research J. Pharm. and Tech. 2019; 12(12): 6049-6056. doi.org/10.5958/0974-360X.2019.01050.3.
26. López-Moreno A, Aguilera M. Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis. J Clin Med. 2021; 10(7):1461. https://doi.org/10.3390/jcm10071461.
27. Rajesh Z. Mujoriya. Analytical Method Development and Validation of Pharmaceutical Technology: An Overview . Research J. Pharma. Dosage Forms and Tech. 2013; 5(4): 213-220. doi.org/10.5958/0975-4377.
28. Rajesh Z. Mujoriya. Analytical Method Development and Validation of Pharmaceutical Technology: An Overview . Research J. Pharma. Dosage Forms and Tech. 2013; 5(4): 213-220. doi.org/10.5958/0975-4377.
29. Harsha Achanta, Suneetha V. Isolation and Biochemical Characterization of Probiotic Lactobacillus Species Isolated from Curd Samples of Southern Regions of Vellore, Tamil Nadu. Research J. Pharm. and Tech. 2017; 10(6): 1734-1741. doi.org/10.5958/0974-360X.2017.00306.7.
30. Diyah Tri Utami, Sylvia Utami Tunjung Pratiwi, Tetiana Haniastuti, Triana Hertiani. Degradation of Oral Biofilms by Zerumbone from Zingiber zerumbet (L.). Research J. Pharm. and Tech. 2020; 13(8): 3559-3564. doi.org/10.5958/0974-360X.2020.00629.0.
31. Singhal L, Gupta V, Gupta M, Goel P, Chander J. Identification and Sensitivity of Vaginal and Probiotic Lactobacillus species to Urinary Antibiotics. J Lab Physicians. 2020; 12(02): 111-4. https://doi.org/10.1055/s-0040-1716604
32. Ocana V, Silva C, Nader-Macías ME. Antibiotic Susceptibility of Potentially Probiotic Vaginal Lactobacilli. Infect Dis Obstet Gynecol. 2006; (1)6. https://doi.org/10.1155/idog/2006/18182
33. Kalinichenko SV, Korotkykh OO, Tishchenko IIu. The topical areas of creation and improvement of probiotics (review). Ukr. biofarmatsevt. zhurn. 2016; (1(42): 4-10. https://doi.org/10.24959/ubphj.16.1
34. Homayouni A, Bastani P, Ziyadi S, Mohammad-Alizadeh-Charandabi S, Ghalibaf M, Mortazavian AM, Mehrabany EV. Effects of Probiotics on the Recurrence of Bacterial Vaginosis. J Low Genit Tract Dis. 2014; 18(1): 79-86. https://doi.org/10.1097/lgt.0b013e3182915
35. Tetiana Nehoda et. al. / Pharmacoeconomic analysis - the way to optimization of using the health budget / Journal of Global Pharma Technology. 2020; 12(9): 15 – 18.